These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 1606772
1. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis. Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS. Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772 [Abstract] [Full Text] [Related]
2. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy. Shearman JD, Yin ZG, Aarons I, Smith PS, Woodroffe AJ, Clarkson AR. Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041 [Abstract] [Full Text] [Related]
3. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH. Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083 [Abstract] [Full Text] [Related]
4. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial. Walker RG, Yu SH, Owen JE, Kincaid-Smith P. Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560 [Abstract] [Full Text] [Related]
5. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. Cameron JS, Healy MJ, Adu D. Q J Med; 1990 Feb; 74(274):133-56. PubMed ID: 2189149 [Abstract] [Full Text] [Related]
6. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency. du Buf-Vereijken PW, Wetzels JF. Nephrol Dial Transplant; 2006 Feb; 21(2):389-96. PubMed ID: 16234291 [Abstract] [Full Text] [Related]
7. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy. Kosmadakis G, Filiopoulos V, Smirloglou D, Skarlas P, Georgoulias C, Michail S. Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839 [Abstract] [Full Text] [Related]
8. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later. Woo KT, Lee GS, Lau YK, Chiang GS, Lim CH. Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661 [Abstract] [Full Text] [Related]
9. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group. Branten AJ, Wetzels JF. Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653 [Abstract] [Full Text] [Related]
12. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P. Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252 [Abstract] [Full Text] [Related]
13. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V. J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881 [Abstract] [Full Text] [Related]
14. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity. du Buf-Vereijken PW, Wetzels JF. Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191 [Abstract] [Full Text] [Related]